Telavancin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA)
Candace Y Hooper, Winter J SmithDepartment of Pharmacy, Clinical and Administrative Sciences, University of Oklahoma Health Sciences Center College of Pharmacy, Oklahoma City, OK, USAAbstract: Telavancin is a bactericidal lipoglycopeptide antibiotic that is structurally related to vancomycin. It dem...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2012-03-01
|
| Series: | Therapeutics and Clinical Risk Management |
| Online Access: | http://www.dovepress.com/telavancin-for-the-treatment-of-nosocomial-pneumonia-caused-by-methici-a9510 |